Circulating Tumor DNA Profiling Identifies Actionable Mutations as Prognostic Markers in Advanced Neuroendocrine Tumors

Neuroendocrinology · Published 2025-09-09 · DOI 10.1159/000548256

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1159/000548256

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Are There Connections between the Neuroendocrine and Dopamine Systems in Bipolar Disorder? · Neuroendocrinology · 2025 · Same journal
• Epidemiology and Health Impacts of Neuroendocrine Tumours · Neuroendocrinology · 2025 · Same journal
• Foxiangsan Modulates Dopaminergic and Motilin Pathways to Improve Gastrointestinal Motility in Diabetic Gastroparesis · Neuroendocrinology · 2026 · Same journal
• Neural Innervation of Adipose Tissue: Current Understanding and Future Perspective · Neuroendocrinology · 2026 · Same journal
• GLP-1 Is Not Enough: Can Glucagon Fill the Energy Expenditure Gap? · Neuroendocrinology · 2026 · Same journal
• Smoking Adversely Affects Survival of Metastatic Lung Carcinoid Patients: Analysis of a Large International Audit and Prognostic Models for Metastasis-Free Survival and Overall Survival · Neuroendocrinology · 2025 · Same journal
• A Novel Relationship between Corticotropin-Releasing Hormone Level and High-Altitude Hypoxia in Human and Rat Model · Neuroendocrinology · 2025 · Same journal
• Medial Preoptic Nucleus to Periaqueductal Gray GABAergic Pathway Underlies Individual Differences in Consolation-Like Behavior in Mice · Neuroendocrinology · 2026 · Same journal
• Is Hypothalamic Dysfunction a Cause of Type II Diabetes Mellitus? · Neuroendocrinology · 2026 · Same journal
• Steroids and One-Carbon Metabolism: Clinical Implications in Endocrine Disorders · Neuroendocrinology · 2025 · Same journal